Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.33

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (9919)	1/5/2004 7:40:56 PM
From: Biomaven	Read Replies (1) of 52153

To return to "on topic", (or perhaps "on topic,") I note the Repligen autism trial failed today. So now the key question becomes whether their CTLA4 RA use patent is worth anything in the context of the BMY trial. When I last looked it wasn't on the patent site yet. Any idea how long from Allowance to being posted on the site? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next